Author: admin

  • Neta’s struggle in Thailand highlights pressure on smaller Chinese EV firms as BYD dominates and incentives tighten

    Neta’s struggle in Thailand highlights pressure on smaller Chinese EV firms as BYD dominates and incentives tighten

    Hyper-competition in China’s electric vehicle sector is spilling over to its biggest market in Asia, Thailand, as smaller players struggle to compete with dominant BYD (002594.SZ), putting ambitious local production plans at risk.

    Neta, among the earliest Chinese EV brands to enter Thailand in 2022, is an example of a struggling automaker finding it difficult to meet the requirements of a demanding government incentive programme meant to boost Thai EV production.

    Under the scheme, carmakers are exempt from import duties, but were obligated to match import volumes with domestic production in 2024.

    Citing slowing sales and tightening credit conditions, carmakers asked the government to adjust the scheme and the 2024 production shortfall was rolled over into this year.

    Neta has said that it cannot produce the required number of cars locally and the government has withheld some payments to the EV maker, said Excise Department official Panupong Sriket, who received a complaint filed last month by 18 Neta dealers in Thailand seeking to recover over 200 million baht ($6.17 million) of allegedly unpaid debt.

    The complaint, a copy of which was reviewed by Reuters, also detailed missed payments by Neta related to promised support for building showrooms and after-sales service.

    “I stopped ordering more cars in September because I sensed something was wrong,” said Neta dealership owner Saravut Khunpitiluck. “I’m currently suing them.”

    Neta’s parent company, Zhejiang Hozon New Energy Automobile, entered bankruptcy proceedings in China last month, according to state media.

    Neta and its Chinese parent did not respond to Reuters’ requests for comment.

    Market share decline

    Neta’s share of Thailand’s EV market peaked at around 12% of EV sales in 2023 when the industry was growing, according to Counterpoint Research data, with BYD having a 49% share that year.

    In Thailand, a regional auto production and export hub, Chinese brands dominate the EV market with a combined share of more than 70%.

    The number of Chinese EV brands has doubled in the last year to 18, placing pressure on those that lack the reach of BYD, which has taken over from Tesla (TSLA.O) as the world’s biggest EV maker.

    In the first five months of this year, new registration of Neta cars — a proxy for sales — slumped 48.5% from the prior year and its share of EV registrations was down to 4%, according to government data.

    “Neta’s downturn in Thailand reflects the fragility of second-tier Chinese EV brands both at home and abroad,” said Abhik Mukherjee, an automotive analyst at Counterpoint Research.

    “Intense price competition and the scale advantages of dominant players have made survival increasingly difficult for smaller companies, particularly in export markets, where margins are slim and robust after-sales support is essential.”

    In Thailand, Neta’s biggest international market, it sells three models, with the cheapest Neta V-II Lite priced at 549,000 baht ($16,924) before discounts, compared to market leader BYD’s entry-level Dolphin model that is priced at 569,900 baht.

    Thailand’s domestic auto market has become increasingly competitive amid a sluggish economy.

    “Some Chinese brands have slashed prices by more than 20%,” said Rujipun Assarut, assistant managing director of KResearch, a unit of Thai lender Kasikornbank. “Pricing has become the main strategy to stimulate buying.”

    China’s EV overcapacity and price war have pushed automakers to expand abroad, but markets like Thailand are now mirroring the same hyper-competitive pressures, exposing smaller firms to similar risks.

    ‘No confidence’

    Three years ago, Thailand unveiled an ambitious plan to transform its car industry, long dominated by Japanese majors like Toyota (7203.T) and Honda (7267.T), to ensure at least 30% of its total auto production was EVs by 2030.

    The country, which exports about half of its auto output, has drawn more than $3 billion in investments from a clutch of Chinese EV makers, including Neta, who were partly lured to Southeast Asia’s second-largest economy by the government incentive scheme.

    “Neta’s case should give the Thai policymakers pause,” said Ben Kiatkwankul, partner at Bangkok-based government affairs advisory firm, Maverick Consulting Group.

    Last December, after a sharp sales contraction, Thailand’s Board of Investment gave EV makers an extension to the initial local production timeline to avoid oversupply and a worsening price war.

    Under the original scheme, local EV production in 2024 was required to match each vehicle imported between February 2022 to December 2023 or the automaker would incur hefty fines.

    Car manufacturers avoided those fines with the extension carrying over unmet production into this year, but at a higher ratio of 1.5 times imports.

    Thailand’s Board of Investment said in a statement to Reuters on Saturday that Neta’s issues were related to the financial situation of its parent firm and did not affect the Thai EV industry in the long term.

    “The Thai government remains committed to the automotive sector and continues to promote policies supporting the EV industry and related technologies,” it said.

    Siamnat Panassorn, vice president of the Electric Vehicle Association of Thailand, said Neta’s issues were company-specific and did not reflect flaws in Thai policies or the market.

    But external shocks, including geopolitical tensions and the spectre of higher tariffs, have added to the pressure felt by the sector, he said.

    For Thai Neta dealers like Chatdanai Komrutai, the crisis is deepening. The brand’s car owners have taken to social media in droves to share maintenance issues and limited after-sales support, and a consumer watchdog agency is inspecting some of those complaints.

    “Selling cars is difficult right now,” Chatdanai said. “There’s no confidence.”


    Continue Reading

  • Ulefone Armor X16: New rugged smartphone with giant battery and night vision camera

    Ulefone Armor X16: New rugged smartphone with giant battery and night vision camera

    The Armor X16 is a rugged smartphone without 5G. (Image source: Ulefone)

    The Armor X16 is a new rugged smartphone that not only features a robust design but also a flashlight. Other features include a large battery, multiple cameras and an IR blaster.

    Ulefone has a new smartphone in its range, the Armor X16, which can be ordered as a direct import from China for $168. Buyers should keep in mind, however, that local warranty rights will not apply in the event of a claim. Ulefone already has a strong presence on Amazon with models such as the Armour 34 Pro 5G, so warranty-conscious customers are advised to wait until the model is available there.

    The Armor X16 is a rugged smartphone that supposedly meets IP69K, IP68, and MIL-STD-810H standards, offering protection against dust, water and falls. The weight of just under 395 grams and the thickness of 17.95 millimeters are due not only to the robust design but also to the large battery, which has a whopping capacity of 10,360 mA and can be charged at 33 watts.

    The MediaTek Helio G91 SoC is a chip without an integrated 5G modem, so users are limited to LTE connections. 6 GB of RAM and 128 GB of internal storage are installed. The 6.56-inch IPS display, reinforced by Corning Gorilla Glass 5, has a resolution of 1,612 x 720, a refresh rate of 90 Hz and a specified peak brightness of 910 cd/m², which, if true, would be a very high value for such a display. Other features include a 48 MP main camera, a 2 MP macro camera and a 20 MP night vision camera. Fingerprint unlocking is supported. Lastly, the operating system is Android 15.
     

    Both a flashlight and an IR blaster are available. (Image source: Ulefone)
    Both a flashlight and an IR blaster are available. (Image source: Ulefone)

    Continue Reading

  • Vietnam’s Q2 GDP accelerates to 7.96% as exports surge; US trade deal eases tariff concerns

    Vietnam’s Q2 GDP accelerates to 7.96% as exports surge; US trade deal eases tariff concerns

    Vietnam’s economy grew at a faster pace in the second quarter of this year, led by strong exports, in an encouraging sign just days after U.S. President Donald Trump said he would place lower-than-threatened 20% tariffs on many Vietnamese products.

    Concerns over the Southeast Asian manufacturing hub’s outlook had been growing in the run-up to the trade deal announced on Wednesday, particularly as the United States is Vietnam’s biggest export market.

    Gross domestic product growth in the April–June quarter accelerated to 7.96% year-on-year, up from 6.93% in the first quarter, government data showed on Saturday. It was just short of Hanoi’s full-year growth target of at least 8%.

    “Economic performance in the first half of this year was positive and close to our target amid global and regional economic uncertainties,” the National Statistics Office (NSO) said.

    Exports were a bright spot in the last quarter, rising 18.0% to $116.93 billion from a year earlier, while imports were up 18.8% at $112.52 billion, translating into a trade surplus of $4.41 billion, NSO data showed.

    Industrial production in the period rose 10.3%, while June consumer prices rose 3.57%.

    Trump announced on Wednesday that the United States and Vietnam reached a trade deal, under which Vietnamese goods would face a 20% tariff, with trans-shipments from third countries through Vietnam also facing a 40% levy. Vietnam could import U.S. products with a zero percent tariff.

    The tariff rates were lower than an initial 46% rate threatened by Trump in April.

    Vietnam hailed the deal as a boost for business and said negotiators were working to finalise details, as business groups awaited clarity on the finer points to assess the impact of the new tariffs.

    The United States is the largest export market for Vietnam, a regional manufacturing hub housing several multinational companies such as Samsung Electronics and Foxconn. The United States recorded a trade deficit of $123 billion with Vietnam last year, one of its highest globally.

    Vietnam is also home to several Chinese companies, which analysts said are likely the main targets for the 40% tariff on trans-shipments. China is Vietnam’s largest two-way trading partner, on which it relies heavily for components and materials for its manufacturing industries.

    Fitch Solutions said in a note on Friday that Vietnam’s exports and investment will remain strong for the rest of the year and signalled upside risks for its 2025 GDP growth forecast of 6.4%.

    “With the new 20% tariff, we think the government will speed up industrial upgrading and shift exports from low-margin goods to higher value-added products such as semiconductors,” Fitch noted.

    Dominic Scriven, founder and chairman of investment firm Dragon Capital, said the trade deal is “net-positive” and the potential GDP hit is less severe than feared.

    “With external trade risk now moderating, attention can return to the country’s core growth engine, the domestic and private sector economy,” he added.


    Continue Reading

  • Xiaomi Laser Projector 3: 4K projector launches with a range of modern features

    Xiaomi Laser Projector 3: 4K projector launches with a range of modern features

    Laser Projector 3: New laser projector with gimbal. (Image source: Xiaomi)

    Xiaomi has a new laser projector on offer, the Xiaomi Laser Projector 3. The device reportedly delivers 4K resolution and comes with an integrated gimbal. Wi-Fi and Bluetooth are also on board for what is a relatively affordable price.

    Xiaomi already has a number of various projectors on offer, such as the Smart Projector L1, and is now adding another projector to its range. The main highlight of the Xiaomi Laser Projector 3 is the 4K resolution, which is said to offer a sharp display at a projection of up to 120 inches (3 meters); hardly any television comes close to this size. However, there is a limitation that is not unusual for cheaper projectors: the specified brightness of 1,000 CVIA lumens is quite low, especially compared to projectors with a conventional light source. The specification in CVIA lumens is not comparable with the commonly used ANSI lumens, and there are certainly legal disputes between various manufacturers regarding the specification of lumens.

    The BT.2020 color space is said to be 110% reproducible and a contrast ratio of 1,600:1 is specified. The model is equipped with a gimbal, which should make setup easier. Also included are a ToF module and a camera for real-time projection adjustment. Automatic keystone correction is also supported. Furthermore, the projector has an SoC, RAM and internal storage, so it can be used without an external player (which can be connected via HDMI 2.1 if desired). Two speakers are installed, each with an output of 8 watts.

    The Xiaomi Laser Projector 3 will be available in China from July 10 for the equivalent of around $660. Information on a global launch is still pending.
     

    Strong color reproduction is advertised. (Image source: Xiaomi)
    Strong color reproduction is advertised. (Image source: Xiaomi)

    Continue Reading

  • Oasis Excite As ‘Oasis Live ‘25’ Reunion Tour Kicks Off In Cardiff

    Oasis Excite As ‘Oasis Live ‘25’ Reunion Tour Kicks Off In Cardiff

    “Said it’s good to be back, good to be back,” sang vocalist Liam Gallagher, improvising a bit as Oasis took to the stage Friday night in Cardiff, Wales with “Hello,” the opening track from the band’s 1995 sophomore studio effort (What’s the Story) Morning Glory.

    It was the first Oasis performance in 16 years and the band – brothers Liam and Noel Gallagher, who took to the stage hand in hand, guitarists Gem Archer and Paul “Bonehead” Arthurs, bassist Andy Bell and drummer Joey Waronker – performed for about two hours in front of 62,000 as the “Oasis Live ‘25” reunion tour kicked off at a sold out Principality Stadium.

    “It was momentous for me and I think for a lot of people,” said Daniel Boczarski, a fan who travelled from Chicago, Illinois to Wales for the event. “Especially culturally for the U.K. fans: to be there and see that they actually did pull this off after so many years was special,” he said. “I saw grown men crying tears of joy and teenagers taking selfies,” said Boczarski, illustrating the group’s cross-generational appeal. “It was just a good, fun time. And that’s what rock and roll should be about.”

    Fans bounced along as Oasis dusted off “Acquiesce” second in the set, the B-side to the group’s first U.K. #1 “Some Might Say,” which the band offered up two songs later.

    “Acquiesce” also appeared on the 1998 Oasis compilation The Masterplan and was recently released as an acoustic remix, the first single from the group’s forthcoming 30th anniversary reissue of (What’s the Story) Morning Glory, due October 3, 2025 on CD or vinyl and for online streaming via Big Brother Recordings.

    Christian Madden handled keyboards with Alastair White (trombone), Joe Auckland (trumpet) and Steve Hamilton (saxophone) chipping in on “Half the World Away.”

    Fans from around the world made the voyage to Cardiff to capture a moment in music history many thought would never happen, a reunion which moves to America with a sold out appearance August 28 at Chicago’s Soldier Field before continuing abroad into late November.

    “For my friends and I, it’s the trip of a lifetime. My friend Matt loves Oasis, so he couldn’t miss it,” said Michael Hurcomb a photographer by trade who will be attending the upcoming Oasis performance as a fan in London on July 25, the first of a five night run at Wembley Stadium, making the trip from Toronto in the Canadian province of Ontario. “My wife and I have never been to England and we were planning a group trip. So, when Oasis announced the tour we knew we had to go,” he said. “We had to be up at 3AM to try to get tickets for Ireland. I had four tickets in my cart but, at the last minute, Ticketmaster didn’t like that I had multiple tabs open and booted me out,” said Hurcomb, echoing the frustrations of fans globally with the ticketing giant during the initial on sale last October. “At 4AM, the England shows went on sale and I got a really low queue number for Wembley. So, I waited it out and got outstanding seats.”

    Opening the encore with “The Masterplan,” Oasis called it a night on stage in Cardiff in epic fashion.

    “Right you beautiful people,” said Liam, introducing Oasis’ closing rendition of “Champagne Supernova” following “Wonderwall.” “This is it!”

    Continue Reading

  • Here’s the Reason Why Temu, AliExpress Prices Increased in Pakistan – ProPakistani

    1. Here’s the Reason Why Temu, AliExpress Prices Increased in Pakistan  ProPakistani
    2. Taxes unnerve e-commerce platforms  Dawn
    3. A comment on Finance Act 2025—IV  Business Recorder
    4. Courier Companies Announce Increase in Delivery Charges After New Taxes  ProPakistani
    5. AliExpress halts low-cost shipping to Sri Lanka amid tax reforms  Ada Derana

    Continue Reading

  • Oasis dedicate 'Live Forever' to Jota in return after 16-year hiatus – Euronews.com

    1. Oasis dedicate ‘Live Forever’ to Jota in return after 16-year hiatus  Euronews.com
    2. Remembering Diogo Jota, a star whose loss is felt beyond Liverpool  ESPN
    3. Diogo Jota: Liverpool forward dies in car accident in Spain  Sky Sports
    4. Liverpool soccer player Diogo Jota, his brother killed in car accident  CBC
    5. Diogo Jota funeral live: Family and football stars gather for Liverpool forward’s funeral  BBC

    Continue Reading

  • Karachi receives new rain spell – ARY News

    1. Karachi receives new rain spell  ARY News
    2. Heavy rain forecast across Punjab on Ashura  The Express Tribune
    3. Are Karachi authorities prepared for next spell of monsoon rains?  Dawn
    4. KP on high alert as PDMA warns of increased risk of GLOFs as monsoon rains intensify  Pakistan Today
    5. Another Warning  Daily Times

    Continue Reading

  • Saif Ali Khan’s ancestral property declared ‘enemy property’; Rs 15,000 Crore fortune at risk

    Saif Ali Khan’s ancestral property declared ‘enemy property’; Rs 15,000 Crore fortune at risk

    In a major legal setback for Bollywood star Saif Ali Khan, the Madhya Pradesh High Court has upheld the Indian government’s decision to declare his inherited family property in Bhopal as ‘enemy property’, putting a massive estate worth Rs 15,000 crore at risk of seizure.

    The court’s decision comes nearly a decade after the Enemy Property Supervisory Department issued a notice in 2014, classifying the Pataudi family’s sprawling estates in Bhopal under the Enemy Property Act and ordering their confiscation. Though Saif Ali Khan managed to secure a stay order against the move in 2015, that protection has now been lifted.

    Properties under contention include some of Bhopal’s most historic and lavish estates: Flagstaff House (where Saif spent much of his childhood), Noor Al-Sabah Palace, Darul Salam, Habibi’s Bungalow, Ahmedabad Palace, and the Kohifza estate, among others.

    The High Court’s ruling also revives a complex inheritance dispute, sending the matter back to the trial court to decide whether only Sajida Sultan (Saif’s grandmother and daughter of the last Nawab of Bhopal, Hamidullah Khan) and her descendants are the rightful heirs, or if other heirs under Muslim Personal Law also have a claim. The trial court has been directed to deliver a decision within a year.

    What is the Enemy Property Act?

    The Enemy Property Act allows the Indian government to take possession of properties owned by individuals who migrated to Pakistan or China after Partition. In this case, the twist lies in the migration of Abida Sultan, Hamidullah Khan’s eldest daughter, to Pakistan in 1950. The Indian government argues that this migration makes the Bhopal estate “enemy property”, even though Sajida Sultan, the second daughter, stayed in India and married Nawab Iftikhar Ali Khan Pataudi—making Saif Ali Khan her direct descendant.

    What’s Next?

    The verdict puts Saif Ali Khan’s potential inheritance—estimated at over Rs 15,000 crore—on the line, and opens the door to a prolonged legal battle. Whether or not the Pataudi scion and his family will retain any part of their princely legacy now lies in the hands of the trial court, which must navigate a labyrinth of personal law, historical context, and geopolitical classification.

    This royal inheritance dispute now threatens to become one of the most high-profile legal property battles in modern Indian history.


    Continue Reading

  • Zanidatamab Combo Has Meaningful Activity in HER2+ Gastroesophageal Cancer

    Zanidatamab Combo Has Meaningful Activity in HER2+ Gastroesophageal Cancer

    “[F]irst-line treatment with zanidatamab plus chemotherapy demonstrated rapid and durable antitumor activity with promising survival outcomes in patients with HER2-positive advanced gastroesophageal adenocarcinoma,” according to the study authors.

    Combining zanidatamab-hrii (Ziihera) with chemotherapy as frontline treatment produced clinically meaningful and enduring activity in a small cohort of patients with HER2-positive advanced gastroesophageal adenocarcinoma, according to primary results from a phase 2 study (NCT03929666) published in Lancet Oncology.1

    The study treatment yielded a confirmed objective response rate (ORR) of 76.2% (95% CI, 60.5%-87.9%) among 42 evaluable patients, which included complete responses (CRs) in 3 patients (7%) and partial responses (PRs) in 29 (69%). The median duration of response (DOR) was 18.7 months (95% CI, 10.4-44.1), and the post hoc median time to first response was 1.3 months (IQR, 1.3-1.4).

    Data showed a median progression-free survival (PFS) of 12.5 months (95% CI, 8.2-21.8), with estimated PFS rates of 57% (95% CI, 40%-70%) at 12 months and 31% (95% CI, 17%-46%) at 24 months. Additionally, treatment elicited a median overall survival (OS) of 36.5 months (95% CI, 23.6-not estimable [NE]), a 12-month OS rate of 87% (95% CI, 72%-94%), and a 24-month OS rate of 65% (95% CI, 49%-77%).

    “[F]irst-line treatment with zanidatamab plus chemotherapy demonstrated rapid and durable antitumor activity with promising survival outcomes in patients with HER2-positive advanced gastroesophageal adenocarcinoma. Zanidatamab plus chemotherapy in the first-line setting was well tolerated with a manageable safety profile when incorporating antidiarrheal prophylaxis in the first 7 days of treatment,” lead study author Elena Elimova, MD, from the Department of Gastrointestinal Medical Oncology at Princess Margaret Cancer Centre in Toronto, Ontario, Canada, wrote with coauthors in the publication.1 “If these results are confirmed in a large-scale, randomized, phase 3 trial, zanidatamab could represent a substantial advancement in the treatment of HER2-positive advanced gastroesophageal adenocarcinoma.”

    In the open-label, multi-center phase 2 study, patients received zanidatamab in combination with capecitabine plus oxaliplatin (CAPOX), 5-fluorouracil (5-FU) plus cisplatin (FP), or leucovorin plus 5-FU and oxaliplatin (mFOLFOX6). In the CAPOX and FP groups, patients received zanidatamab at 30 mg/kg, 1800 mg with a weight of less than 70 kg, or 2400 mg with a weight of 70 kg or higher every 3 weeks. In the mFOLFOX6 group, patients received zanidatamab at 20 mg/kg, 1200 mg with a body weight under 70 kg, or 1600 mg with a weight of at least 70 kg every 2 weeks.

    In part 1 of the trial, investigators evaluated the safety and tolerability of zanidatamab plus chemotherapy to determine a recommended phase 2 dose; the primary end points of this part were dose-limiting toxicities and dose reductions. In part 2 of the trial, the primary end point was investigator-assessed confirmed ORR per RECIST v1.1 criteria. Secondary efficacy endpoints across parts 1 and 2 of the trial included disease control rate, DOR, clinical benefit rate, PFS, and OS.

    Patients 18 years and older with unresectable, locally advanced, recurrent, or metastatic HER2-expressing gastroesophageal adenocarcinoma and measurable disease per RECIST v1.1 guidelines were eligible for enrollment on the trial.2 Other eligibility criteria included having an ECOG performance status of 0 or 1, adequate organ function, and adequate cardiac left ventricular function.

    The median patient age was 58 years (IQR, 55-63), and most of the population was male (85%), White (61%), and not Hispanic (93%). Additionally, most patients had an ECOG performance status of 0 (57%), gastric anatomical subtype disease (41%), stage IV disease at initial diagnosis (83%), and measurable disease (93%). Prior neoadjuvant or adjuvant chemotherapy was reported in 11% of patients.

    In a subgroup of patients with centrally confirmed HER2-positive disease (n = 41), zanidatamab-based therapy produced a confirmed ORR of 84% (n = 31/37; 95% CI, 68.0%-93.8%). Furthermore, the median PFS was 15.2 months (95% CI, 9.5-33.4) in this subgroup, and the median OS was 36.5 months (95% CI, 23.6-NE).

    In a post hoc analysis of patients who enrolled on the trial before and after the implementation of antidiarrheal prophylaxis, 61% (n = 14/23; 95% CI, 38.5%-80.3%) and 95% (n = 18/19; 95% CI, 74.0%-99.9%) experienced confirmed responses. Those who received antidiarrheal prophylaxis experienced longer treatment duration and exposure.

    Treatment-related adverse effects (TRAEs) affected 100% of patients, with the most common grade 3/4 TRAEs consisting of diarrhea (39%) and hypokalemia (22%). Additionally, 17% of patients had serious TRAEs, the most common of which was diarrhea (7%).

    The median duration of grade 1/2 or grade 3 diarrhea was 6.5 days (IQR, 2-29) and 3 days (IQR, 2-5), respectively, among patients who enrolled on the trial before the implementation of antidiarrheal prophylaxis. The median durations were 3 days (IQR, 2-13) and 4.5 days (IQR, 3-8) among those who entered the trial following the implementation of antidiarrheal prophylaxis.

    References

    1. Elimova E, Ajani J, Burris H, et al. Zanidatamab plus chemotherapy as first-line treatment for patients with HER2-positive advanced gastro-oesophageal adenocarcinoma: primary results of a multicentre, single-arm, phase 2 study. Lancet Oncol. 2025;26(7):847-859. doi:10.1016/S1470-2045(25)00287-6
    2. A safety and efficacy study of ZW25 (Zanidatamab) plus combination chemotherapy in HER2-expressing gastrointestinal cancers, including gastroesophageal adenocarcinoma, biliary tract cancer, and colorectal cancer. ClinicalTrials.gov. Updated March 13, 2025. Accessed July 1, 2025. https://tinyurl.com/y9d77aay

    Continue Reading